...
mrvi-img

Maravai Lifesciences Holdings Inc, Common Stock

MRVI

NSQ

$5.67

+$0.01

(0.18%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.46B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.19M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.02
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.28 L
$11.55 H
$5.67

About Maravai Lifesciences Holdings Inc, Common Stock

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameMRVISectorS&P500
1-Week Return12.28%-2.27%-0.57%
1-Month Return0.71%-3.96%1.21%
3-Month Return-32.42%-9.7%7.57%
6-Month Return-26.93%-3.37%11.45%
1-Year Return-4.38%3.71%28.48%
3-Year Return-85.89%3.8%29.52%
5-Year Return-81.01%39.78%90.66%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue143.14M284.10M799.24M883.00M288.94M[{"date":"2019-12-31","value":16.21,"profit":true},{"date":"2020-12-31","value":32.17,"profit":true},{"date":"2021-12-31","value":90.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.72,"profit":true}]
Cost of Revenue66.85M79.65M140.56M168.96M148.74M[{"date":"2019-12-31","value":39.57,"profit":true},{"date":"2020-12-31","value":47.14,"profit":true},{"date":"2021-12-31","value":83.19,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.04,"profit":true}]
Gross Profit76.29M204.45M658.68M714.04M140.20M[{"date":"2019-12-31","value":10.68,"profit":true},{"date":"2020-12-31","value":28.63,"profit":true},{"date":"2021-12-31","value":92.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":19.63,"profit":true}]
Gross Margin53.30%71.96%82.41%80.87%48.52%[{"date":"2019-12-31","value":64.67,"profit":true},{"date":"2020-12-31","value":87.32,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.12,"profit":true},{"date":"2023-12-31","value":58.88,"profit":true}]
Operating Expenses51.98M103.55M115.28M147.63M171.85M[{"date":"2019-12-31","value":30.25,"profit":true},{"date":"2020-12-31","value":60.26,"profit":true},{"date":"2021-12-31","value":67.08,"profit":true},{"date":"2022-12-31","value":85.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income23.99M67.60M554.64M574.22M(31.65M)[{"date":"2019-12-31","value":4.18,"profit":true},{"date":"2020-12-31","value":11.77,"profit":true},{"date":"2021-12-31","value":96.59,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.51,"profit":false}]
Total Non-Operating Income/Expense(59.80M)(52.83M)(54.14M)(40.82M)631.32M[{"date":"2019-12-31","value":-9.47,"profit":false},{"date":"2020-12-31","value":-8.37,"profit":false},{"date":"2021-12-31","value":-8.58,"profit":false},{"date":"2022-12-31","value":-6.47,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(5.85M)81.70M530.76M551.47M617.74M[{"date":"2019-12-31","value":-0.95,"profit":false},{"date":"2020-12-31","value":13.23,"profit":true},{"date":"2021-12-31","value":85.92,"profit":true},{"date":"2022-12-31","value":89.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes(652.00K)2.88M61.52M60.81M756.11M[{"date":"2019-12-31","value":-0.09,"profit":false},{"date":"2020-12-31","value":0.38,"profit":true},{"date":"2021-12-31","value":8.14,"profit":true},{"date":"2022-12-31","value":8.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(5.20M)78.82M469.25M490.66M(138.38M)[{"date":"2019-12-31","value":-1.06,"profit":false},{"date":"2020-12-31","value":16.06,"profit":true},{"date":"2021-12-31","value":95.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-28.2,"profit":false}]
Income From Continuous Operations(5.20M)78.82M469.25M490.66M59.04M[{"date":"2019-12-31","value":-1.06,"profit":false},{"date":"2020-12-31","value":16.06,"profit":true},{"date":"2021-12-31","value":95.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":12.03,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(5.20M)76.89M469.25M490.66M(119.03M)[{"date":"2019-12-31","value":-1.06,"profit":false},{"date":"2020-12-31","value":15.67,"profit":true},{"date":"2021-12-31","value":95.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-24.26,"profit":false}]
EPS (Diluted)-0.111.591.80(0.02)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":6.11,"profit":true},{"date":"2021-12-31","value":88.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.11,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MRVI
Cash Ratio 9.14
Current Ratio 10.74
Quick Ratio 9.94

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MRVI
ROA (LTM) -1.61%
ROE (LTM) -42.93%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MRVI
Debt Ratio Lower is generally better. Negative is bad. 0.52
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.27

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MRVI
Trailing PE NM
Forward PE 370.37
P/S (TTM) 5.17
P/B 2.33
Price/FCF 315
EV/R 2.84
EV/Ebitda 1.44

FAQs

What is Maravai Lifesciences Holdings Inc share price today?

Maravai Lifesciences Holdings Inc (MRVI) share price today is $5.67

Can Indians buy Maravai Lifesciences Holdings Inc shares?

Yes, Indians can buy shares of Maravai Lifesciences Holdings Inc (MRVI) on Vested. To buy Maravai Lifesciences Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MRVI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Maravai Lifesciences Holdings Inc be purchased?

Yes, you can purchase fractional shares of Maravai Lifesciences Holdings Inc (MRVI) via the Vested app. You can start investing in Maravai Lifesciences Holdings Inc (MRVI) with a minimum investment of $1.

How to invest in Maravai Lifesciences Holdings Inc shares from India?

You can invest in shares of Maravai Lifesciences Holdings Inc (MRVI) via Vested in three simple steps:

  • Click on Sign Up or Invest in MRVI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Maravai Lifesciences Holdings Inc shares
What is Maravai Lifesciences Holdings Inc 52-week high and low stock price?

The 52-week high price of Maravai Lifesciences Holdings Inc (MRVI) is $11.55. The 52-week low price of Maravai Lifesciences Holdings Inc (MRVI) is $4.28.

What is Maravai Lifesciences Holdings Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Maravai Lifesciences Holdings Inc (MRVI) is

What is Maravai Lifesciences Holdings Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Maravai Lifesciences Holdings Inc (MRVI) is 2.33

What is Maravai Lifesciences Holdings Inc dividend yield?

The dividend yield of Maravai Lifesciences Holdings Inc (MRVI) is 0.00%

What is the Market Cap of Maravai Lifesciences Holdings Inc?

The market capitalization of Maravai Lifesciences Holdings Inc (MRVI) is $1.46B

What is Maravai Lifesciences Holdings Inc’s stock symbol?

The stock symbol (or ticker) of Maravai Lifesciences Holdings Inc is MRVI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top